-
Impact and Challenges of the COVID-19 Pandemic on Patients Requiring Botulinum Toxin A Treatment
- Azalea Tenerife Pajo, Adrian Isidoro Espiritu, Roland Dominic Go Jamora
-
J Mov Disord. 2021;14(1):29-33.
-
Viewpoint
January 12, 2021
|
-
Involuntary Movements Following Administration of Hydroxychloroquine for COVID-19 Pneumonia
- Emmaline Zantua Fernando, Jeryl Ritzi Tan Yu, Salvador Miclat Abad Santos, Roland Dominic Go Jamora
-
J Mov Disord. 2021;14(1):75-77.
-
Case Report
December 7, 2020
|
-
Deep Brain Stimulation Battery Exhaustion during the COVID-19 Pandemic: Crisis within a Crisis
- Vikram Venkappayya Holla, Koti Neeraja, Bharath Kumar Surisetti, Shweta Prasad, Nitish Kamble, Dwarakanath Srinivas, Ravi Yadav, Pramod Kumar Pal
-
J Mov Disord. 2020;13(3):218-222.
-
Brief communication
August 31, 2020
|
-
COVID-19: Implications for Sudden Death in Parkinson’s Disease
- Ana Claudia Fiorini, Marcelo Cunio Machado Fonseca, Carla Alessandra Scorza, Josef Finsterer, Antônio Márcio Rodrigues, Antônio-Carlos Guimarães de Almeida, Fulvio Alexandre Scorza
-
J Mov Disord. 2021;14(1):78-80.
-
Letter to the editor
August 31, 2020
|
-
COVID-19: An Early Review of Its Global Impact and Considerations for Parkinson’s Disease Patient Care
- Roongroj Bhidayasiri, Sasivimol Virameteekul, Jong-Min Kim, Pramod Kr. Pal, Sun-Ju Chung
-
J Mov Disord. 2020;13(2):105-114.
-
Review Article
April 30, 2020
|